HIV Positive Clinical Trial
Official title:
Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
The investigators are interested in understanding personal factors such as medical conditions
and mental health, as well as social and economic factors, that influence marijuana (and
other substance) use in HIV-positive patients.
Several alternative hypotheses will be evaluated in the proposed project:
1. healthier patients may self-select marijuana use;
2. marijuana use may be associated with consequences that create barriers to seeking
healthcare;
3. marijuana use may have medicinal value that reduces the need for such care.
The study will involve a total of 5 interviews with clinical research staff members, the
total involvement will be for about 1 year.
The first interview will establish a baseline of current behaviors and health status; this
will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building,
located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in
length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each
follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to
assess changes in behaviors and health status over time.
We will collect urine samples at each of the 5 interview sessions to assess health and
illicit drug use.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00639145 -
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
|
||
| Completed |
NCT01152684 -
Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
|
||
| Completed |
NCT01957748 -
CCTG 594: Engagement and Retention in Care for HIV+
|
N/A | |
| Completed |
NCT01818258 -
IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
|
Phase 4 | |
| Withdrawn |
NCT03660722 -
Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects
|
N/A | |
| Completed |
NCT01793467 -
Transplantation and the Use of Raltegravir in HIV-Infected Patients
|
N/A | |
| Completed |
NCT02938377 -
Alcohol Research Consortium in HIV-Intervention Research Arm
|
Phase 4 | |
| Completed |
NCT01898754 -
Oligonucleotide Ligation Assay (OLA) Resistance Study
|
N/A | |
| Active, not recruiting |
NCT01365065 -
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
|
Phase 2 | |
| Completed |
NCT00106795 -
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
|
N/A | |
| Not yet recruiting |
NCT02404233 -
Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects
|
Phase 4 | |
| Completed |
NCT01154543 -
Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
|
N/A | |
| Completed |
NCT01154556 -
RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
|
N/A | |
| Completed |
NCT00857350 -
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
|
N/A | |
| Recruiting |
NCT01875588 -
Thinking and Memory Problems in People With HIV
|
||
| Completed |
NCT01941121 -
CCTG 593: Testing and Linkage to Care
|
N/A | |
| Terminated |
NCT01904201 -
Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
|
N/A | |
| Enrolling by invitation |
NCT00941889 -
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
|
N/A | |
| Completed |
NCT03531749 -
Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate
|
N/A | |
| Completed |
NCT02935296 -
Integrated Treatment and Prevention for People Who Inject Drugs
|
Phase 3 |